Phentermine Completed Phase 4 Trials for Obesity Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT04408586Anti-Obesity Phentermine-Topiramate Extended Release Pharmacotherapy vs Placebo Among Patients Using a Wearable Activity Tracker
NCT03779048Use of Medication to Improve Weight Loss in Suboptimal Early Responders to Behavioral Treatment
NCT01834404Peripheral Pharmacodynamics of Phentermine-Topiramate in Obese Patients
NCT01922934A Toolbox Approach to Obesity Treatment in Primary Care
NCT02229214Effect of VI-0521 (Qsymia®) on Glomerular Filtration Rate (GFR) in Overweight or Obese Healthy Subjects
NCT02911818Lifestyle Modification and Liraglutide